Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing NeedsPRNewsWire • 07/31/26
Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 07/29/26
Are You Looking for a Top Momentum Pick? Why Elanco Animal Health Incorporated (ELAN) is a Great ChoiceZacks Investment Research • 07/22/26
Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets)PRNewsWire • 07/22/26
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results AnnouncementPRNewsWire • 07/08/26
Is the Options Market Predicting a Spike in Elanco Animal Health Stock?Zacks Investment Research • 06/30/26
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal HealthPRNewsWire • 06/18/26
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for DogsPRNewsWire • 06/15/26
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World ScrewwormPRNewsWire • 06/04/26
New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry ResiliencePRNewsWire • 06/03/26
Elanco Animal Health Incorporated (ELAN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks TranscriptSeeking Alpha • 06/02/26
Elanco Animal Health Incorporated (ELAN) Presents at Stifel Jaws & Paws Conference 2026 TranscriptSeeking Alpha • 05/27/26
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology MarketPRNewsWire • 05/18/26
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/06/26
Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/29/26
Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in LivestockPRNewsWire • 04/27/26
Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results AnnouncementPRNewsWire • 04/16/26
Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*PRNewsWire • 04/09/26